Arylsulfatase B activity was studied in peripheral leukocytes obtained from 11 normal subjects, 2 obligate heterozygotes for Maroteaux-Lamy syndrome (MLS), and 1 homozygote for MLS. The activity (mean & SD) vyas 113.7 & 36.2 (range 57.4-181.81, 31.0 (25.7-34.5), and 3.0 nmol 4-nitrocatechol/mg proteinlhr, respectively. Although overlap occurred on two occasions between adjacent groups on single enzyme determinations, no overlap was observed between normal subjects, heterozygotes, and the homozygote when the mean activities of replicate assays performed were considered. In two normal siblings of the patient, sibling 1 and sibling 2, the activity was 50.1 and 106.3, respectiveljl. Arylsulfatase B activity in cultured skin fibroblasts derived from 14 normal subjects, the 2 obligate heterozygotes for MLS, and the patient was 145.2 4.6 (82.7-178.7), 58.5 (49.3-67.6), and 7.0, respectively. Occasional overlap between normal subjects and heterozygotes again occurred with single enzyme determinations, but there was no overlap between the mean values of replicate assays performed on each case. Sibling I and sibling 2 showed activity of 51.0 and 96.0, respectively, confirming the leukocytes. Arylsulfatase B activity in cultured skin fibroblasts of 11 patients with 7 other inborn errors of metabolism, including patients with Hurler's syndrome, Hunter's syndrome, and metachromatic leukodystrophy was within normal range. The lysosomal enzymes arylsulfatase A (EC. 3. 
Extract
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Speculation
Deficiency of arylsulfatase B is the basic metabolic defect in Maroteaux-Lamy syndrome. This enzyme probably catalyzes the cleavage of sulfate from the sulfated N-acetylgalatosamine contained in dermatan sulfate. Its deficiency would result in tissue accumulation and urinary excretion of this mucopolysaccharide.
The Maroteaux-Lamy syndrome, first described in 1963 (16) , is characterized by growth deficiency, coarse facies, corneal opacities, dysostosis multiplex, hepatosplenomegaly, cardiac valvular disease, normal or near normal intelligence, and an autosomal recessive mode of inheritance (17) . There is increased urinary excretion of acid mucopolysaccharides, 70--95% of which is dermatan sulfate. Barton and Neufeld ( I ) have identified in the urine of normal subjects a specific factor that corrects the metabolic defect in cultured skin fibroblasts derived from patients with MLS. This factor was barely detectable in the medium of normal cultured skin fibroblasts. It has been reported that the activity of 12 lysosomal enzymes was normal in a patient with MLS, but the enzymes studied were not specified, except for a-arabinosidase and (3-galactosidase, which were in the lower range of normal values (22) .
Stumpf and Austin (23) originally observed deficiency of arylsulfatase B in the liver of a patient with MLS. Later Stumpf et a/. (24) described deficiency of arylsulfatase B in the liver, kidney, spleen, and brain of patients with MLS. They also reported deficiency of arylsulfatase B in cultured skin fibroblasts derived from a patient with MLS, but the enzymatic activities in the patient and control subjects were not specified. Arylsulfatase B activity of about 10% of that in normal subjects has recently been observed in cultured skin fibroblasts obtained from patients with M L S by Fluharty et a/. (9) .
We have found deficiency of arylsulfatase B activity in peripheral leukocytes, cultured skin fibroblasts, and a lymphoid cell line derived from a patient with M L S and have been able to identify the carrier state of the disease in fresh leukocytes and cultured skin fibroblasts.
MATERIALS AND METHODS
The patient, a female, JT260569 (i.e., born May 26, 1969) had I normal'psychomotor development. Kyphosis and prominent forehead were first noted at the age of 2 years. At the age of 4.5 years her height was below the 3rd percentile, she had coarse facies, prominent forehead, corneal opacities, lumbar kyphosis, stiff joints, umbilical hernia, mild hepatosplenomegaly, and dysostosis multiplex. Figure 1 shows the patient at the age of 3.5 years. The total amount of acid mucopolysaccharides in the urine at the age of 2.5 years was 12.9 mg, more than 90% of which was dermatan sulfate (26) .
PERIPHERAL LEUKOCYTES
Heparinized blood was obtained from the patient, the patient's parents, and two siblings, and from 11 normal donors. Five parts of blood were mixed with I part of 6% dextran and the erythrocytes were allowed to settle for 30 min. The supernatant leukocyte-rich fraction was centrifuged and for complete removal of erythrocytes the resulting pellet was resuspended in 0.5 ml normal saline and 2 ml 0.83% NH,Cl. After 5 min at room temperature the cell suspension was centrifuged and, in cases where erythrocytes were still present in the pellet, the above procedure was repeated. Erythrocyte-free leukocytes were washed three times with normal saline and cells were stored at -80' until enzyme determinations were performed.
CULTURED SKIN FIBROBLASTS, CULTURED AMNIOTIC FLUID CELLS, AND LYMPHOID CELL LINES
Skin biopsy was obtained from the inner surface of the forearm of the patient, the patient's parents, 2 phenotypically normal siblings, and 14 normal subjects. Skin fibroblasts grown from the biopsy tissue were cultivated in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 20% fetal calf serum (27) , 1% 200 m M L-glutamine, 100 U / m l penicillin, and 100 pg/ml streptomycin (28).
Amniotic fluid was obtained from normal pregnancies by transabdominal amniocentesis between the 16th and 19th week of gestational age. Amniotic fluid cells were cultured in R P M I 1640 medium supplemented with 30% fetal calf serum L-glutamine and antibiotics.
After the growth of a sufficient number of cells, cultures were passed in 75 cm2 flasks (29) and kept in an atmosphere of 10% CO, in air. Cultures were fed regularly twice a week. All cells used in enzymatic assays were derived from cultures in the early confluent stage, between the third and eighth subculture for skin fibroblasts and third and fifth passage for amniotic fluid cells. Cells were fed and were harvested 24 hr later after a I-min exposure to 0.25% trypsin and subsequently to 0.02% sodium ethylenediaminetetraacetic acid in isotonic saline for 20 min. Cells were washed three times and stored at -80°. For the culture cycle experiment normal skin fibroblasts were grown to confluence and subsequently trypsinized and subcultured into multiple culture flasks. Every 2 days thereafter, up to the loth day from the trypsinization, cells were harvested for enzyme determinations. Cells grew logarithmically from days 1 through 5, when they reached the stationary phase.
Cultured skin fibroblasts of the patient were examined by Dr. Elizabeth F. Neufeld from the National Institutes of Health and demonstrated excessive accumulation of 35S0,-mucopolysaccharides. The metabolic defect was corrected with addition to the culture medium of the Maroteaux-Lamy factor.
Ten long term lymphoid cell lines established from normal donors, one line derived from the patient with MLS, and five lines derived from patients with other inborn errors of metabolism were used in the study. Lines were established, using a technique which we described earlier (4) , that combines stimulation of peripheral leukocytes with phytohemagglutinin and incubation with EpsteinBarr virus or phytohemagglutinin stimulation alone (5) . The lymphoid lines were fed with the same medium as cultured skin fibroblasts. Twenty-four hours before harvesting, lines were fed with fresh medium. The lymphoid cells were washed three times with isotonic saline and stored a t -80' Cells were lysed in distilled water by eight cycles of rapid freezing and thawing. The lysates were centrifuged at 1,800 x g for 5 min and the supernatant fractions were used for enzymatic determinations.
E N Z Y M E ASSAYS activity was measured in fibroblast lvsates with 4-methylumbellifeEnzyme activities of arylsulfatase A and B were determined using p-nitrocatechol sulfate as substrate. a-L-Iduronidase was measured using phenyl-a-L-iduronide (30) . Other enzymatic activities were determined utilizing either the p-nitrophenyl or the 4-methylumbelliferyl substrate derivatives. Substrates were supplied by Sigma Chemical Co. (31) . except 4-methylumbelliferyla-D-mannoside, which was obtained from Koch-Light Laboratories (32) .
Arylsulfatase A activity was determined in cell lysates by the method of Baum et al. (2) , as adapted for peripheral leukocytes (20) and cultured skin fibroblasts (13) , except that a shorter incubation period of 30 min was used. In peripheral leukocytes and lymphoid lines excess protein was removed from the final digest by heating in boiling water and by centrifugation (3) .
Arylsulfatase B activity in peripheral leukocytes, cultured skin fibroblasts, and cultured amniotic fluid cells was measured by incubating 100 p1 of cell lysate (normal leukocytes, 175-330 pg proteinltube; leukocytes homozygous and heterozygous for MLS, 390-800 pg protein; normal fibroblasts, 150-245 pg protein; fibroblasts homozygous and heterozygous for MLS, 300-380 pg protein; and 230-290 pg amniotic fluid cell protein) with 400 p1 0.0625 M p-nitrocatechol sulfate in 0.5 M acetate buffer containing M barium acetate, pH 6.0. The reaction was incubated at 37" and after 30 and 90 min, 160 pl digest were transferred to tubes containing 160 p1 I N NaOH. In lymphoid lines, 525-975 pg proteinltube were used and excess protein was removed by heating the final digests and the blank in boiling water for 90 sec and centrifuging at 1,800 x g. The activities at 30 and 90 min, after taking account of contributions from the blank, were used as described by Baum et al. (2) to estimate the contribution by arylsulfatase A. The difference is expressed as arylsulfatase B activity. The amount of 4-nitrocatechol released was linear between 140 and 800 pg leukocyte proteinltube. 140--380 p g fibroblast proteinltube, and 400-1,100 pg lymphoid cell line proteinltube. Decreased specific activities were obtained when lower protein concentrations were used.
Acid a-glucosidase activity was measured in cell lysates using maltose as substrate by a modification of the method of Nitowsky and Grunfeld (19) . a-Galactosidase activity was determined colorimetrically in lysates by the method of Kint (14) using p-nitrophenyl-a-D-galactoside. a-L-Iduronidase was determined in fibroblast homogenates as previously described by Hall and Neufeld (1 I). a-L-Fucosidase activity was measured in fibroblast lysates by a modification of the method of Zielke et al. (25) . The concentration of p-nitrophenyl-a-L-fucoside in the reaction mixture was increased to 3 m M , and the incubation time was reduced to 2 hr. a-D-Mannosidase activity was estimated in lysates with 4-methylumbelliferyl-a-D-mannoside at pH 4.4. P-Galactosidase ryl-P-D-galactoside according to the method of HO-et al. (12) . P-Glucosidase was measured in fibroblast homogenates with 4-methylumbelliferyl-0-D-glucoside (12) , except that Triton X-100 was not added. P-Glucuronidase activity was determined by using p-nitrophenyl-P-D-glucuronide as previously described (10) except that a shorter incubation period of 2 hr was used. Protein was measured by the method of Lowry et al. (15) . All assays were carried out in duplicate. The released 4-nitrocatechol and p-nitrophenol were measured against a blank at 515 and 420 nm, respectively. The fluorescence of 4-methylumbelliferone was measured at 450 nm after excitation at 360 nm. Student's t test was employed for the statistical analysis of the data. studied, the enzyme activity fell within the heterozygous values. Also in I out of 12 lysates studied from the 2 obligate heterozygotes the enzyme activity overlapped with a high value obtained in a lysate of the patient's leukocytes. In two other cell lysates from the patient, no arylsulfatase B activity was detected. Table 2 lists the activity of arylsulfatase B in culturcd skin fibroblasts derived from 14 normal donors, 2 obligate heterozygotes for MLS, 1 homozygote for MLS, 2 siblings of the patient, and 11 patients with seven other inborn errors of metabolism. Table 3 lists the specific activities of nine other lysosomal enzymes in cultured skin fibroblasts of the above subjects. The values in the patient's skin fibroblasts fell within the control range for each enzyme. No deficiency of arylsulfatase B was detected in the fibroblasts of the other inborn errors of metabolism studied. Mixing experiments between lysates of normal and deficient cultured skin fibroblasts gave the expected enzymatic activities.
RESULTS P E R I P H E R A L LEUKOCYTES

C U L T U R E D S K I N FIBROBLASTS. C U L T U R E D A M N I O T I C F L U I D CELLS, A N D L.YMPIHO1D CELL 1-INES
In the culture cycle experiment the arylsulfatase B activity fell to the lowest level on the 4th day after trypsinization and thereafter it increased steadily. On the loth day the activity was almost double between normal subjects and obligate heterozygotes, as well as heterozygotes and homozygotes are highly significant (t = 6.3979, P < 0.0005, and t = 7.8265, P < 0.0005, respectively).
Mean + SD. t h a t observed o n t h e 4th day. T h e a-L-fucosidase studied in t h e s a m e cell lysates a s arylsulfatase B followed a different pattern of activity (Fig. 2) . I n T a b l e 4 a r e listed t h e activities of arylsulfatase A a n d B 
T a b l e 3. Activity of nine lysosomaf enzymes in cultured skin ,fibroblasts derived from 14 normal subjects, a palient with Maroteaux-Lam.v syndrome ( M L S ) , the patient's parents and siblings, and 1 I patients with seven various inborn errors of metabolism1
DISCUSSION
O u r results demonstrate deficiency of arylsulfatase B activity in fresh peripheral leukocytes, cultured skin fibroblasts, a n d a long t e r m lymphoid cell line derived from a documented case of MLS.
T h e activity in t h e patient's leukocytes a n d skin fibroblasts w a s 4.6 a n d 4.8% of t h e activity in t h e normal cells, respectively, whereas n o activity was detected in t h e Maroteaux-Lamy lymphoid line.
T h e activity in leukocytes a n d cultured skin fibroblasts obtained f r o m t h e patient's parents was 26.5 a n d 40.3% o f t h e control values, respectively. I n occasional single determinations overlap ' Enzyme activity is expressed in nanomoles of 4-nitrocatechol per milligram of protein per hour.
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individuals. The apparent permanence and remarkable prolifera--.
tive ability of the lymphoid lines make them excellent tools for detailed studies of the metabolic defect in MLS. Other metabolic disorders already detected in lines are the Lesch-Nyhan syndrome (6), metachromatic leukodystrophy (3), citrullinemia (21), cystic fibrosis (7) , and homocystinuria (8) .
The finding that arylsulfatase B activity is present in cultured amniotic fluid cells suggests that prenatal diagnosis of the M L S is feasible. Determination of the normal range of values in a sufficient number of control cultures and study of more than one preparation of the cultured amniotic fluid cells of the fetus at risk The severe deficiency of arylsulfatase B activity in three different tvoes of cells derived from the oatient with M L S and the between the enzyme activity of normal donors and heterozygotes was observed. This overlap could possibly be attributed to limitations of the assay system or changes in the culture conditions. Since care was taken to harvest the cells at the same growth phase and because similar variation in enzyme activity was also observed in some peripheral leukocyte assays, it seems likely that the variation is caused by technical difficulties inherent in the assay system. However, when the mean activities of the assays performed on each case were considered, a clear delineation between homozygotes, heterozygotes, and control subjects was obtained. It appears that for the reliable identification of the carrier state of M L S at least two peripheral leukocyte or cultured skin fibroblast lysates of a given individual should be studied.
One of the patient's siblings demonstrated arylsulfatase B activity within the normal range in both peripheral leukocytes and cultured skin fibroblasts, suggesting that she is homozygous for the wild type allclc at the Marotcaux-Lamy locus. Thc othcr sibling showed. in verivheral leukocytes, 44.1% activity of the control values, that Is, higher than 26.j% activity observed in the obligate heterozygote parents. Cultured skin fibroblasts of the same subject demonstrated arylsulfatase B activity well within the heterozygote range, suggesting that she is a carrier for MLS.
The drop of arylsulfatase B activity during the growth phase of the fibroblasts and subsequent increase of activity during confluence indicate that cultures should be stopped at the same growth phase. Since the growth rate of skin fibroblasts from different individuals varies considerably, cultures should be observed before harvesting.
The absence of arylsulfatase B activity demonstrated in a long term lymphoid line established from the patients with M L S indicates that the line maintained the genotype of the donor and that lymphoid lines can be used for the study of affected 2 > reduced enzymatic activity in leukocytes and cultured skin fibroblasts from heterozygotes indicate that deficiency of arylsulfatase B is the basic metabolic defect of this inborn error of mucopolysaccharide metabolism. This enzyme probably catalyzes the cleavage of sulfate from the sulfated N-acetylgalactosamine contained in derniatan sulfate.
Recently O'Brien et al. (19) reported deficiency of N-acetylgalactosamine-4-sulfatase (EC. 3.1.6.*) in cultured skin fibroblasts obtained from two patients with MLS. However, two other patients with the clinical picture of M L S studied by O'Brien and Cantz demonstrated normal activity of this enzyme (unpublished data cited in Reference 19) . This apparent contradiction may be due to heterogeneity already suggested on clinical evidence (21) .
It appears that use of the artificial substrate p-nitrocatechol sulfate provides an easy .method for the diagnosis of M L S in various cell types. Our findings also confirm the autosomal recessive mode of inheritance of M L S and indicate that carrier detection is possible.
SUMMARY
Arylsulfatase B deficiency was demonstrated in peripheral leukocytes, cultured skin fibroblasts, and a lymphoid line derived from a patient with MLS. The patient's parents demonstrated levels of arylsulfatase B that were intermediate between those found in the patient and those in control subjects. The activity (mean -I-SD) in leukocytes from normal subjects, the patient's parents, and the patient was 113.7 + 36.2, 31.0, and 5.2 nmol 4-nitrocatechol/mg proteinlhr, respectively. in skin fibroblasts of the same subjects the activity was 145.2 * 41.6, 58.5, and 7.0, respectively. Nine other lysosomal enzymes were normal in skin fibroblasts of the patient. N o arylsulfatase B activity was detected in a lymphoid line established from the patient with MLS. The arylsulfatase B activity in cultured amniotic fluid cells from 10 normal pregnancies was 203.2 49.9.
